Uncategorised - European Medical Journal

Increasing Natural Substance in the Blood Could Help Treat Depression

Depression could potentially be treated by boosting blood levels of a substance produced naturally in the body called acetyl-L-carnitine, according to…

European Medical Journal Presents: EMJ Hematology 6.1

The European Medical Journal has published the latest edition of the EMJ Hematology eJournal. Click here to find out more

Study Could Help Overcome Resistance to a Common Cancer Treatment

Cancer cell resistance to PARP inhibitor therapy could be overcome following the discovery of various mechanisms that lay behind this resistance. The…

NGS in PH+ LEUKEMIA: WATCH AN INTERVIEW WITH DR SOVERINI

Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in…

Planning Your Next Move in Philadelphia Chromosome Positive Leukaemias

The meeting was arranged as a series of conversations between experts, following a question and answer format with two speakers in each presentation…

Polymorphisms in Multidrug Resistance Transporter Genes Affect the Duration of Molecular Response to Nilotinib in Chronic Myeloid Leukaemia Patients

Despite the high efficacy and improved clinical response of nilotinib in chronic myeloid leukaemia (CML), there is still a significant proportion of…

Review of the 23rd European Hematology Association Congress 2018

A warm welcome to the EMJ Hematology review of the landmark 23rd annual congress of the European Hematology Association (EHA).

Editor's Pick: Allogeneic Haematopoietic Stem Cell Transplantation for Chronic Myeloid Leukaemia in the Era of Tyrosine Kinase Inhibitors

The introduction of tyrosine kinase inhibitors (TKI) has dramatically improved the prognosis of chronic myeloid leukaemia (CML) patients and, therefore…

Inherited Platelet Disorders Caused by Thrombopoietin Mutation

Thrombopoietin (THPO) and the interaction with its receptor c-Mpl have a nonredundant role in platelet biogenesis and maintenance of the haematopoietic…

Therapeutic Options in Myelodysplastic Syndromes: Established and Emerging Therapies

Although hypomethylating agents (HMA) have revolutionised the treatment of myelodysplastic syndromes (MDS), a significant proportion of patients either…